Literature DB >> 10829076

Prothrombotic phenotype of protein Z deficiency.

Z F Yin1, Z F Huang, J Cui, R Fiehler, N Lasky, D Ginsburg, G J Broze.   

Abstract

Protein Z (PZ) is a vitamin K-dependent plasma protein whose function has been uncertain. The structure of PZ is very similar to that of the coagulation-related factors VII, IX, and X and PC, but PZ differs from these other proteins in that it is not the zymogen of a serine protease. We have shown recently that PZ forms a calcium ion-dependent complex with activated factor X at phospholipid surfaces and that this interaction leads to the inhibition of activated factor X activity through, in part, the action of a previously unidentified plasma protein named PZ-dependent protease inhibitor. Herein, we report that the presence of PZ dampens the coagulation response in human plasma and that concomitant PZ deficiency dramatically increases the severity of the prothrombotic phenotype of factor V(Leiden) mice. The results indicate that PZ plays a physiologically important role in the regulation of coagulation.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10829076      PMCID: PMC18721          DOI: 10.1073/pnas.120081897

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Comparison of naturally occurring vitamin K-dependent proteins: correlation of amino acid sequences and membrane binding properties suggests a membrane contact site.

Authors:  J F McDonald; A M Shah; R A Schwalbe; W Kisiel; B Dahlbäck; G L Nelsestuen
Journal:  Biochemistry       Date:  1997-04-29       Impact factor: 3.162

2.  Evolution of blood coagulation activators and inhibitors in the healthy human fetus.

Authors:  P Reverdiau-Moalic; B Delahousse; G Body; P Bardos; J Leroy; Y Gruel
Journal:  Blood       Date:  1996-08-01       Impact factor: 22.113

Review 3.  Thrombophilia as a multigenic disorder.

Authors:  U Seligsohn; A Zivelin
Journal:  Thromb Haemost       Date:  1997-07       Impact factor: 5.249

4.  Inherited resistance to activated protein C is corrected by anticoagulant cofactor activity found to be a property of factor V.

Authors:  B Dahlbäck; B Hildebrand
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

5.  Tissue factor pathway inhibitor gene disruption produces intrauterine lethality in mice.

Authors:  Z F Huang; D Higuchi; N Lasky; G J Broze
Journal:  Blood       Date:  1997-08-01       Impact factor: 22.113

6.  Mutation in blood coagulation factor V associated with resistance to activated protein C.

Authors:  R M Bertina; B P Koeleman; T Koster; F R Rosendaal; R J Dirven; H de Ronde; P A van der Velden; P H Reitsma
Journal:  Nature       Date:  1994-05-05       Impact factor: 49.962

7.  Isolation of a protein Z-dependent plasma protease inhibitor.

Authors:  X Han; R Fiehler; G J Broze
Journal:  Proc Natl Acad Sci U S A       Date:  1998-08-04       Impact factor: 11.205

8.  Inactivation of the gene for anticoagulant protein C causes lethal perinatal consumptive coagulopathy in mice.

Authors:  L R Jalbert; E D Rosen; L Moons; J C Chan; P Carmeliet; D Collen; F J Castellino
Journal:  J Clin Invest       Date:  1998-10-15       Impact factor: 14.808

9.  Peptide bond cleavages and loss of functional activity during inactivation of factor Va and factor VaR506Q by activated protein C.

Authors:  G A Nicolaes; G Tans; M C Thomassen; H C Hemker; I Pabinger; K Varadi; H P Schwarz; J Rosing
Journal:  J Biol Chem       Date:  1995-09-08       Impact factor: 5.157

10.  Activated protein C resistance: molecular mechanisms based on studies using purified Gln506-factor V.

Authors:  M J Heeb; Y Kojima; J S Greengard; J H Griffin
Journal:  Blood       Date:  1995-06-15       Impact factor: 22.113

View more
  37 in total

1.  The Jeremiah Metzger Lecture. Hypercoagulable states: challenges and opportunities.

Authors:  R L Nachman
Journal:  Trans Am Clin Climatol Assoc       Date:  2001

2.  Protein Z levels in pregnant Omani women: correlation with pregnancy outcome.

Authors:  Vaidyanathan Gowri; Mariam Mathew; David Gravell; Karima AlFalahi; Ibrahim Zakwani; Shyam S Ganguly; Anil V Pathare
Journal:  J Thromb Thrombolysis       Date:  2011-11       Impact factor: 2.300

3.  Plasma protein Z concentrations in pregnant women with idiopathic intrauterine bleeding and in women with spontaneous preterm labor.

Authors:  Juan Pedro Kusanovic; Jimmy Espinoza; Roberto Romero; Debra Hoppensteadt; Jyh Kae Nien; Chong Jai Kim; Offer Erez; Eleazar Soto; Jawed Fareed; Sam Edwin; Tinnakorn Chaiwerapongsa; Nador G Than; Bo Hyun Yoon; Ricardo Gomez; Zoltan Papp; Sonia S Hassan
Journal:  J Matern Fetal Neonatal Med       Date:  2007-06

Review 4.  The importance of factor Xa regulatory pathways in vascular thromboresistance: focus on protein Z.

Authors:  Richard C Becker
Journal:  J Thromb Thrombolysis       Date:  2005-04       Impact factor: 2.300

5.  Mutations R67X and W303X of the protein Z-dependent protease inhibitor gene and venous thromboembolic disease: a case-control study in Italian subjects.

Authors:  Dora Fabbro; Giovanni Barillari; Giuseppe Damante
Journal:  J Thromb Thrombolysis       Date:  2007-02       Impact factor: 2.300

6.  Lipid oxidation inactivates the anticoagulant function of protein Z-dependent protease inhibitor (ZPI).

Authors:  Xin Huang; Baoxin Liu; Yidong Wei; Ryan Beyea; Han Yan; Steven T Olson
Journal:  J Biol Chem       Date:  2017-07-17       Impact factor: 5.157

7.  Heparin cofactor II inhibits arterial thrombosis after endothelial injury.

Authors:  Li He; Cristina P Vicente; Randal J Westrick; Daniel T Eitzman; Douglas M Tollefsen
Journal:  J Clin Invest       Date:  2002-01       Impact factor: 14.808

8.  Cloning of matrix Gla protein in a marine cartilaginous fish, Prionace glauca: preferential protein accumulation in skeletal and vascular systems.

Authors:  J B Ortiz-Delgado; D C Simes; C S B Viegas; B J Schaff; C Sarasquete; M L Cancela
Journal:  Histochem Cell Biol       Date:  2006-01-13       Impact factor: 4.304

9.  Identification of factor Xa residues critical for interaction with protein Z-dependent protease inhibitor: both active site and exosite interactions are required for inhibition.

Authors:  Alireza R Rezaie; Chandrashekhara Manithody; Likui Yang
Journal:  J Biol Chem       Date:  2005-08-03       Impact factor: 5.157

10.  Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A.

Authors:  T J Girard; N M Lasky; K Grunz; G J Broze
Journal:  J Thromb Haemost       Date:  2018-12-16       Impact factor: 5.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.